Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Control : Journal of the Moffitt Cancer Center|December 7, 2011
Clinical and laboratory prognostic indicators in chronic lymphocytic leukemiaElizabeth M Sagatys, Ling Zhang
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
Follicular lymphoma with progression to diffuse large B-cell lymphoma and concurrent CD5-negative mantle cell lymphoma-3 entities in a lymph nodeJanese A Trimaldi, Jeremy W Bowers, Celeste Bello, et al.
International Journal of Clinical and Experimental Pathology|January 19, 2013
Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literatureReza Setoodeh, Stuart Schwartz, Peter Papenhausen, et al.
Leukemia Research|November 14, 2013
Current pathology practices in and barriers to MDS diagnosisTerry Ann Glauser, Elizabeth M Sagatys, J Chad Williamson, et al.
Journal of Leukocyte Biology|February 10, 2015
CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic responseBrian C Betts, Elizabeth M Sagatys, Anandharaman Veerapathran, et al.
Life Science Alliance|April 22, 2024
Porphyrin overdrive rewires cancer cell metabolismSwamy R Adapa, Gregory A Hunter, Narmin E Amin, et al.
The Journal of Clinical Investigation|May 22, 2020
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host diseaseBishwas Shrestha, Kelly Walton, Jordan Reff, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2018
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiationBrian C Betts, David Bastian, Supinya Iamsawat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial ResultsJoseph Pidala, Kelly Walton, Hany Elmariah, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2021
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repairKelly Walton, Kirsti Walker, Megan Riddle, et al.
Pageof 2